EP
GBT

Edgestream Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Edgestream Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,226
Closed -$1.92M – 665
2022
Q3 		$1.92M Buy
+28,226
New +$1.56M 0.15% 197

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Edgestream Partners's GBT Position: Q4 2022 in Review

Edgestream Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 28,226 shares — an estimated $1.92M sold.

Edgestream Partners first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $1.92M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Edgestream Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Edgestream Partners sold 28,226 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.92M.
  • Edgestream Partners first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Edgestream Partners's Global Blood Therapeutics, Inc. position peaked at $1.92M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Edgestream Partners's 13F filing for Q4 2022, filed 13 Feb 2023.